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Abstract
Objective
To evaluate whether ethnicity is independently associated with vaginal microbiota (VMB)
composition in women living in Amsterdam, the Netherlands, as has been shown for Ameri-
can women.
Methods
Women (18–34 years, non-pregnant, N = 610) representing the six largest ethnic groups
(Dutch, African Surinamese, South-Asian Surinamese, Turkish, Moroccan, and Ghanaian)
were sampled from the population-based HELIUS study. Sampling was performed irrespec-
tive of health status or healthcare seeking behavior. DNA was extracted from self-sampled
vaginal swabs and sequenced by Illumina MiSeq (16S rRNA gene V3-V4 region).
Results
The overall prevalence of VMBs not dominated by lactobacilli was 38.5%: 32.2% had a
VMB resembling bacterial vaginosis and another 6.2% had a VMB dominated by Bifidobac-
teriaceae (not including Gardnerella vaginalis), Corynebacterium, or pathobionts (strepto-
cocci, staphylococci, Proteus or Enterobacteriaceae). The most prevalent VMB in ethnically
Dutch women was a Lactobacillus crispatus-dominated VMB, in African Surinamese and
Ghanaian women a polybacterial G. vaginalis-containing VMB, and in the other ethnic
groups a L. iners-dominated VMB. After adjustment for sociodemographic, behavioral and
PLOS ONE | https://doi.org/10.1371/journal.pone.0181135 July 11, 2017 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Borgdorff H, van der Veer C, van Houdt R,
Alberts CJ, de Vries HJ, Bruisten SM, et al. (2017)
The association between ethnicity and vaginal
microbiota composition in Amsterdam, the
Netherlands. PLoS ONE 12(7): e0181135. https://
doi.org/10.1371/journal.pone.0181135
Editor: David N. Fredricks, Fred Hutchinson Cancer
Research Center, UNITED STATES
Received: March 4, 2017
Accepted: June 27, 2017
Published: July 11, 2017
Copyright: © 2017 Borgdorff et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The HELIUS data are
owned by the Academic Medical Center (AMC) in
Amsterdam, The Netherlands. Any researcher can
request the data by submitting a proposal to the
HELIUS Executive Board as outlined at http://www.
heliusstudy.nl/en/researchers/collaboration.
Requests for further information and proposals can
be submitted to Dr. Marieke Snijder, Scientific
Coordinator and Data Manager of HELIUS, at m.b.
snijder@amc.uva.nl, or to info@heliusstudie.nl. The
“heliusstudy” website and generic email address
will continue to be actively managed in the event
clinical factors, African Surinamese ethnicity (adjusted odds ratio (aOR) 5.1, 95% confi-
dence interval (CI) 2.1–12.0) and Ghanaian ethnicity (aOR 4.8, 95% CI 1.8–12.6) were
associated with having a polybacterial G. vaginalis-containing VMB, and African Surinam-
ese ethnicity with a L. iners-dominated VMB (aOR 2.8, 95% CI 1.2–6.2). Shorter steady rela-
tionship duration, inconsistent condom use with casual partners, and not using hormonal
contraception were also associated with having a polybacterial G. vaginalis-containing
VMB, but human papillomavirus infection was not. Other sexually transmitted infections
were uncommon.
Conclusions
The overall prevalence of having a VMB not dominated by lactobacilli in this population-
based cohort of women aged 18–34 years in Amsterdam was high (38.5%), and women of
sub-Saharan African descent were significantly more likely to have a polybacterial G. vagi-
nalis-containing VMB than Dutch women independent of modifiable behaviors.
Introduction
The majority of women of reproductive age have a vaginal microbiota (VMB) dominated by
lactobacilli [1]. VMB not dominated by lactobacilli are increasingly being recognized as a
cause of adverse reproductive health outcomes, such as increased acquisition and transmission
of HIV (reviewed in [2]) and preterm birth (reviewed in [3]). The clinical condition known as
bacterial vaginosis (BV) is thought to be the most common type of VMB not dominated by lac-
tobacilli [1, 4]. Molecular studies in the last decade have consistently identified the following
anaerobes with high relative abundance in BV cases: Gardnerella vaginalis, Atopobium vaginae,
BVAB1-3, Mobiluncus species, Prevotella species, Sneathia/Leptotrichia species, Megasphaera
species, among others [3]. Other types of VMBs not dominated by lactobacilli, such as VMBs
containing a high relative abundance of pathobionts, have also been identified but less com-
monly [1]. Until recently, many research groups lumped all VMBs not dominated by lactoba-
cilli together into one community state type (CST IV), which was originally described by Ravel
et al in 2011 [5]. An expert consultation organized by the U.S. National Institutes of Health
(NIH) in 2015 called for more detailed descriptions of the various types of VMBs not domi-
nated by lactobacilli and, eventually, subcategorization into multiple CSTs [6]. This is deemed
necessary to improve our understanding of the etiology and pathogenesis of different CSTs
and their sequelae, and to develop targeted interventions.
Another important finding from molecular studies in the last decade is that not all lactoba-
cilli are equal [1]: a VMB dominated by Lactobacillus crispatus is considered more beneficial
than a VMB dominated by L. iners, because the latter is associated with a higher risk of devel-
oping a VMB not dominated by lactobacilli [7] and a higher prevalence of sexually transmitted
infections (STIs) [8].
Known risk factors for BV are unprotected sexual activity (reviewed in [9]), smoking [10],
some types of vaginal cleansing practices (reviewed in [2]), the presence of STIs [11, 12], low
levels of sex hormones [13–15], and African ethnicity (reviewed in [16]). Molecular studies in
asymptomatic American women showed that African-American women are more likely to
have a diverse VMB or a L. iners-dominated VMB than Caucasian or Asian-American women
[5, 17–19]. Molecular studies have also shown that the prevalence of L. crispatus-dominated
Vaginal microbiota and ethnicity
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VMB is much lower in sub-Saharan Africa than in other parts of the world [20, 21]. However,
whether the association between ethnicity and VMB composition is based on sociodemo-
graphic, behavioral, environmental, or genetic factors is still a matter of debate [22, 23]. Molec-
ular studies conducted to date were small and did not adequately control for confounding
factors, and few studies have been done in multi-ethnic European populations [1]. Compari-
sons within and between multi-ethnic populations in different parts of the world may provide
the new insights required to disentangle the effects of sociodemographic, behavioral, environ-
mental, and genetic factors on VMB composition.
In this study, we characterized VMB compositions of women representing the six largest
ethnic groups in Amsterdam, the Netherlands. In keeping with the recommendation by the
recent U.S. NIH consultation, we provide detailed descriptions of all diverse VMBs that we
identified. We also determined factors associated with VMB composition with a focus on
ethnicity.
Materials and methods
Study population
We used baseline data and samples from the HELIUS study, a multi-ethnic cohort study in
Amsterdam, The Netherlands [24]. The HELIUS study aims to unravel the causes of the
unequal burden of disease across ethnic groups residing in Amsterdam, and was approved by
the Medical Ethics Committee of the Academic Medical Center in Amsterdam (protocol num-
ber: 10/100; amendment 10/100# 10.17.1729; NL32251.018.10). All participants provided writ-
ten informed consent.
People aged 18–70 years were randomly sampled by ethnic origin (Dutch, Surinamese,
Moroccan, Turkish, and Ghanaian) through the municipality register of Amsterdam [25]. For
the Dutch sample, we invited people who were born in the Netherlands and whose parents
were born in the Netherlands. For the Turkish sample, Turkish ethnicity was defined as: (a)
born in Turkey and having at least one parent who was born in Turkey (first generation) or
(b) born in the Netherlands but both parents were born in Turkey (second generation). A
similar definition was used for the other ethnic minority groups (Surinamese, Moroccan and
Ghanaian). After data collection, the Surinamese group was further stratified according to
self-reported ethnic origin into ‘African’ (of West-African descent), ‘South-Asian’ (of North-
Indian descent), ‘Javanese’, or ‘other’. In the VMB sub-study, we included African Surinamese
women and women of North-Indian Surinamese or Javanese Surinamese descent (collectively
referred to in this paper as South-Asian Surinamese) as two separate groups.
Between January 2011 and December 2015, HELIUS baseline data were collected for 24,789
participants. For the VMB sub-study, a subsample of women enrolled between 1 January 2011
and 31 December 2013 was selected: all women aged 18–34 years who had provided a self-sam-
pled vaginal swab and had completed the questionnaire on sexual behavior were eligible for
selection, and seven female participants per ethnic group per life year (or all available partici-
pants if fewer than seven were available) were randomly selected [26].
Study procedures
Participants attended the study clinic for one study visit. They provided data on sociodemo-
graphics, behaviors, and medical history online or during the study visit. Participants who
were unable to complete the questionnaire were offered assistance from a trained, ethnically
matched interviewer. They were asked to bring a sample of their first morning urine to their
study visit, which was tested by a urine reagent test strip (Combur 7, Roche). During the study
visit, participants underwent a physical examination and biological sample collection. All
Vaginal microbiota and ethnicity
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women were asked to participate in the VMB sub-study by self-collecting a vaginal swab
(Copan Diagnostics Inc., Murrieta, CA, USA) during the study visit, but refusal to do so did
not render them ineligible for the HELIUS study. The vaginal swabs were kept at 2–8˚C at the
study site for up to six days, and then transported to, and stored at -20˚C, at the Public Health
Laboratory until testing. Women who were pregnant or less than 6 months postpartum were
asked to postpone their HELIUS participation.
VMB characterization
Each vaginal swab was eluted in 800 μl phosphate-buffered saline and divided into four ali-
quots. One aliquot each was tested for Trichomonas vaginalis (Aptima Trichomonas vaginalis
assay, HOLOGIC, Bedford, MA, USA), Chlamydia trachomatis and Neisseria gonorroeae
(Aptima Combo 2, HOLOGIC, Bedford, MA, USA), and human papillomavirus (HPV)
(SPF10-PCR-DEIA/LiPA25 system version 1, DDL, Voorburg, the Netherlands) [26], and the
fourth aliquot was used for VMB characterization. Samples were lysed using chemical lysis
(lysozyme, mutanolysin (Sigma Aldrich, USA, St. Louis), and lysostaphin (AMBI, USA, New
York)) and bead beating (MagnaPure, Roche Diagnostics, Switzerland, Basel), as described by
Ravel [5]. Lysed samples were further treated using proteinase K and RNase A (Thermo Fisher,
USA, Waltham). DNA was extracted using the ChemaGen extraction robot (PerkinElmer,
Germany, Baesweiler). Dual indexed universal primers (319F and 806R) were used for PCR
amplification of the V3-V4 regions of the 16S rRNA genes as described by Fadrosh [27]. PCR
products were pooled and normalized, and purified with Agencourt AMPure XP magnetic
beads (BeckmanCoulter, Fullerton, USA). Paired-end sequencing was performed on the Illu-
mina MiSeq instrument (San Diego, CA, USA).
Preprocessing of raw sequence data
Sequence data were preprocessed as described by Fadrosh [27] with minor modifications. Bar-
codes were trimmed off unaligned sequences. The unaligned sequences were then quality fil-
tered by truncating reads with an average phred score <20 over a 30 bp sliding window with
subsequent removal of sequences truncated to less than 75% of their original length as well as
their paired sequences using Trimmomatic [28]. PANDAseq [29] was used for assembling
paired sequences, error correction, and additional quality filtering: paired-end sequences that
did not overlap or resulted in a sequence of<400 bp were removed. Sequences were matched
to their corresponding barcode using the demultiplex tool in QIIME (version 1.8.0) [30] and
removed when not matched to a barcode, being less than 75% of the original length after qual-
ity truncation, or having any ambiguous base calls. One mismatch was allowed during removal
of PCR primer sequences (Tagcleaner [31]). The USEARCH tool in QIIME [32] was used for
operational taxonomic unit (OTU) picking based on 97% sequence similarity and Greengenes
version 13.8 was used as a reference for chimera detection [33]. Sequences were aligned to
sequences in a vaginal reference package [34] using the PyNAST method in QIIME.
Taxonomic classification
Taxonomic classification of OTUs was performed using two methods: 1) pplacer suite [35]
with the vaginal reference package [34] as reference taxonomy and 2) RDP Classifier in
QIIME with Greengenes version 13.8 [33] as reference taxonomy. The 16S rDNA BLAST
function of the NCBI database was used when the two methods produced discordant results or
when identification at species level was not possible (for OTUs with>1% relative abundance
in at least one sample only). OTUs that were assigned to the same species were merged.
Extremely rare OTUs (a total read count of less than 10) were removed. This resulted in 455
Vaginal microbiota and ethnicity
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OTUs, with 96% mapping to species level, 3% to genus level, and 1% to higher taxonomic
levels.
Data analysis
Statistical analyses were performed using R version 3.1.3 (R Development Core Team, 2015)
and STATA release 12 (StataCorp, College Station, TX, USA). All analyses were cross-sectional
and contained one sample per participant. Samples with<100 high quality reads were excluded
from subsequent analyses. Richness (number of OTUs) and diversity (Shannon Diversity
Index) were calculated for each sample at a rarefied read count of 100. Hierarchical clustering
was performed using Euclidean distance and complete linkage, and the resulting 20 clusters
were visualized in a heatmap. Thirteen of these 20 clusters contained fewer than 10 samples.
Clusters were therefore pooled based on microbiological characteristics to form meaningful
VMB groups (see Table 1 for a detailed description of how this was done). The resulting eight
VMB groups were described and their distribution across ethnic groups assessed. Sociodemo-
graphic, behavioral, and clinical characteristics were compared between HELIUS participants
who did or did not provide a vaginal swab (to explore the magnitude and direction of participa-
tion bias), the six ethnic groups, and the three largest VMB groups (the other five VMB groups
were too small to allow for multivariable modeling). The three largest VMB groups were: 1) L.
crispatus-dominated VMB; 2) L. iners-dominated VMB; and 3) polybacterial G. vaginalis-con-
taining VMB (Table 1). In unadjusted analyses comparing women who did or did not provide a
vaginal swab, and the six ethnic groups, two-sided Chi-squared or Fishers’ exact tests were used
for categorical data, and two-sided Kruskal Wallis tests for continuous data. Two separate mul-
tivariable logistic regression models were used to determine correlates of the L. iners-dominated
VMB group and polybacterial G. vaginalis-containing VMB group, respectively, each compared
to the L. crispatus-dominated VMB group. All covariates that were considered risk factors for a
non-lactobacilli-dominated VMB a priori, and were associated with a VMB group in the unad-
justed analyses at p<0.1, were included in the multivariable models. The proportion of women
who used antibiotics in the past two weeks was small, and not statistically different among eth-
nic groups or VMB groups (see results). Furthermore, a sensitivity analysis excluding recent
antibiotic users did not significantly alter our results and conclusions (data not shown).
Results
Study population
Of the 1,469 women aged 18–34 years who attended a HELIUS baseline visit before January
2014, 980 (67%) self-sampled a vaginal swab and 924 (63%) also completed the sexual behavior
questionnaire. Up to seven women per ethnic group and per life year were randomly selected
from these 924 women, which resulted in a sample size of 610 women. Dutch, African Suri-
namese, South-Asian Surinamese, and Ghanaian women were more likely to provide a vaginal
swab (94%, 87%, 75%, and 71%, respectively) than Turkish and Moroccan women (37% and
49%, respectively; p<0.01; [26]).
The median age of the 610 selected women was 27 years (IQR 22–30), and did not differ
between ethnic groups by design. However, other sociodemographic characteristics, substance
use, reproductive health history, sexual behaviors, and clinical characteristics differed substan-
tially (Table 2). Dutch women were more likely to have attained higher vocational or university
education and to report use of tobacco, cannabis and alcohol, and less likely to report being
religious and to have children. Turkish and Moroccan women were most likely to be married,
Dutch and Surinamese women were most likely to currently use hormonal contraception, and
Dutch and African Surinamese women were most likely to report sexual risk behaviors. Dutch
Vaginal microbiota and ethnicity
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Table 1. VMB cluster composition descriptions, Amsterdam, the Netherlands (2011–2015).
Clusters1 Description (Percentages are relative abundances) N2 VMB group names3 N2
2 L. crispatus-dominated. 85 women had >90%, 44 had 50–90%, and 2 had <50% with L.
jensenii.
131 L. crispatus-dominated 131
1 L. iners-dominated. 94 women had >90%, 81 had 50–90%, and 12 had <50% with other
lactobacilli.4
187 L. iners-dominated 187
7 L. gasseri-dominated. 3 women had >90%, 6 had 50–90%, and 5 had <50% with other
lactobacilli.
13 Other lactobacilli-dominated 18
9 L. jensenii-dominated. 2 women had >90%, and one had 50% L. jensenii and 45% L. gasseri. 3
14 L. delbrueckii-dominated. Both women had 48–61% combined with 17–47% GV. 2
4 Polybacterial with GV>AV or BVAB1. All women had GV (18–77%), 80 also had AV (1–30%),
and 18 BVAB1 (3–18%). Sneathia/Leptotrichia, Megasphaera type 1, Mobiluncus, Prevotella
(but always <20%), and L. iners were common3. Six women had some L. gasseri, two L.
jensenii, and none L. crispatus.
98 Polybacterial GV-containing VMB 134
5 Polybacterial with AV>GV. All 31 women had GV (10–52%) and AV (26–69%), and 3 had
<10% BVAB1. Sneathia/Leptotrichia, Megasphaera type 1, Mobiluncus, Prevotella (but
always <20%), and L. iners were common.5 One woman each had some L. jensenii or L.
crispatus.
31
17 Polybacterial with BVAB1 and GV>AV. All 5 women had BVAB1 (40–47%), GV (4–16%), and
AV (2–33%). Sneathia/Leptotrichia, Megasphaera type 1, Mobiluncus, Prevotella (but always
<20%), and L. iners were common.5 No-one had L. crispatus.
5
3 G. vaginalis-dominated. All 29 women had 75–100% GV.6 29 G. vaginalis-dominated 29
16 Mobiluncus curtisii-dominated (60%) with some GV, AV, and BVABs. 2 Other polybacterial anaerobic VMB 13
6A Polybacterial with low abundance of GV, AV, and BVAB1: 7 women had >20% of Prevotella
spp (21–34%), 3 had 37–44% L. crispatus with anaerobes, and one a mixture of anaerobes.
11
11 Bifidobacteriaceae-dominated, not including GV (59–89%) 3 Bifidobacteriaceae or
Corynebacterium-dominated
14
20 Bifidobacterium-dominated (75–99%) 3
10 Bifidobacterium breve-dominated (40–89%) 4
6B Polybacterial with low abundance of GV, AV, and BVAB1, and >40% Corynebacterium spp
(44–75%)
4
18 Streptococcus–dominated (71%) 1 Pathobiont-dominated 20
8 Streptococcus agalactiae-dominated: 5 women had 62–97%, and 4 had 35–57% with other
pathobionts, Corynebacterium spp, Bifidobacteriaceae, and/or lactobacilli.
9
19 Streptococcus anginosus-dominated (69%) 1
13 Staphylococcus-dominated (82%) 1
12 Escherichia coli-dominated (83%) 1
15 Enterococcus faecalis-dominated (55%), with some S. agalactiae, S. anginosis, and
staphylococci.
2
6C Polybacterial with low abundance of GV, AV, and BVAB1, and >15% pathobionts (15–44%). 5
AV = Atopobium vaginae, BVAB1 = BV-associated bacteria 1; GV = Gardnerella vaginalis, spp = species, VMB = vaginal microbiota.
1These numbers correspond to the 20 hierarchical clusters described in the results. In this table, clusters are organized into biologically meaningful VMB
groups. Each hierarchical cluster was assigned to one biologically meaningful VMB group, except for cluster 6: this cluster was further subdivided into three
groups (referred to as 6A-C), each of which was assigned to a different biologically meaningful VMB group. The hierarchical clustering clustered 6A-C
together because of similar diversity combined with low abundance of GV, AV, and BVAB1, but they were otherwise biologically very different (see
descriptions in the table).
2Number of samples containing the depicted VMB composition.
3VMB composition correlates were only determined for the three pooled clusters shown in bold.
4Two women also had >30% aerobes (37% Psychrobacter; 32% Raoultella planticola).
5Some women also had >1% Actinomycetales, Anaerococcus spp, other BVABs, Clostridiaceae, Corynebacterium spp (but <20%), Dialister spp,
Eggerthella, Finegoldia magna, Parvimonas micra, Peptoniphilus spp, and Veillionella spp. >1% Bifidobacterium spp, Mycoplasmas, Ureaplasmas, and
pathobionts were rare.
6Low levels of the same anaerobes as described for clusters 4, 5 and 17 were also often present.
https://doi.org/10.1371/journal.pone.0181135.t001
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and African Surinamese women also had the highest prevalence of any HPV and high risk
HPV (both p<0.01) [24]. The prevalences of Neisseria gonorrhoeae, Chlamydia trachomatis,
and Trichomonas vaginalis were low and not statistically significantly different across the eth-
nic groups.
VMB compositions in the overall study population
The median number of high quality sequences per sample was 25,392 (IQR 4,654–43,798).
Samples with fewer than 100 sequences (n = 64) were discarded from further analyses; these
were equally distributed across ethnic groups (data not shown). Hierarchical clustering of the
remaining 546 samples resulted in 20 clusters (Fig 1, Table 1), which were pooled into eight
microbiologically meaningful VMB groups as outlined in Table 1.
Three VMB groups were dominated by lactobacilli: L. crispatus-dominated VMB (n = 131,
24.0% of women), L. iners-dominated VMB (n = 187, 34.2%), and ‘other Lactobacillus-domi-
nated’ VMB (pooling clusters dominated by L. gasseri, L. jensenii, and L. delbrueckii; n = 18,
3.3%). Most women in these groups had a VMB with more than 50% relative abundance of the
Fig 1. Hierarchical clustering of participants by VMB composition. AV = Atopobium vaginae; BVAB1 = BV-associated bacterium 1; GV = Gardnerella
vaginalis; L = Lactobacillus; OTU = operational taxonomic unit; VMB = vaginal microbiota. A. The 20 VMB clusters obtained by hierarchical clustering of 546
vaginal samples. Clustering was based on the relative abundance of 455 OTUs. B. Heatmap showing the relative abundance of the most abundant OTUs
using the color key on the left.
https://doi.org/10.1371/journal.pone.0181135.g001
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relevant Lactobacillus species, and women with less than 50% of that species typically had addi-
tional Lactobacillus species. Other bacteria were sometimes present but in much smaller rela-
tive abundance, most commonly G. vaginalis and Corynebacterium. Pathobionts (streptoccoci,
staphylococci, Proteus, and Enterobacteriaceae) were present in 14 women in a relative abun-
dance of 1–14%. Overall, for all ethnic groups combined, 61.5% of the women had a lactoba-
cilli-dominated VMB and 38.5% had another type of VMB.
Three of the five VMB groups that were not dominated by lactobacilli resembled BV. These
included ‘polybacterial G. vaginalis-containing VMB’ (pooling three polybacterial clusters with
high relative abundance of G. vaginalis, A. vaginae and BVAB1 [4]; n = 134, 24.5% of women), ‘G.
vaginalis-dominated VMB’ (n = 29, 5.3%), and ‘other anaerobic polybacterial VMB’ (pooling two
polybacterial clusters with low relative abundance of G. vaginalis, A. vaginae and BVAB1 but high
relative abundance of Mobiluncus, Prevotella species or other anaerobes; n = 13, 2.4%). All of
these women had a polybacterial VMB characterized by the anaerobes that have typically been
associated with BV (see Introduction and Table 1), often in combination with L. iners and several
other minority taxa. Bifidobacteriaceae (not including G. vaginalis) were uncommon in these
VMB groups. The final two of five VMB groups not dominated by lactobacilli included a VMB
group dominated by Bifidobacteriaceae (not including G. vaginalis) or Corynebacterium (n = 14,
2.6%) and a VMB group dominated by pathobionts (n = 20, 3.7%). Overall, 32.2% of all women
had a VMB resembling BV and another 6.2% had a VMB dominated by Bifidobacteriaceae (not
including G. vaginalis), Corynebacterium, or pathobionts.
A total of 33 women (6.0%) distributed over all eight VMB groups had 1% or more relative
abundance of a Streptococcus species, and an additional 18 women (3.3%) had 1% or more rela-
tive abundance of another pathobiont.
Unadjusted associations between ethnicity and VMB groups
The distribution of the eight VMB groups was significantly different among ethnic groups
(Fig 2). The most prevalent VMB group in Dutch women was a L. crispatus-dominated VMB
(38%), in South-Asian Surinamese, Turkish and Moroccan women a L. iners-dominated VMB
(40%, 41%, and 35%, respectively), and in African Surinamese and Ghanaian women a poly-
bacterial G. vaginalis-containing VMB (39% and 34%, respectively). Turkish and Moroccan
women more often had a VMB dominated by Bifidobacteriaceae (not including G. vaginalis),
Corynebacterium or pathobionts than women from the other ethnic groups (11% and 14%,
respectively, versus 2–5%). When comparing the VMB group distribution of each ethnic
group to the distribution in Dutch women (as shown in Fig 2), the Fisher’s exact p values were
0.41 for South Asian Surinamese women, <0.01 for African Surinamese women, 0.08 for Gha-
naian women,<0.01 for Turkish women, and 0.01 for Moroccan women. The VMB of African
Surinamese women had the highest richness (median 6.2, IQR 3.6–9.2) compared to a median
richness of 4.2–5.2 in the other ethnic groups (overall Kruskal Wallis p = 0.02). The median
Shannon Diversity Index [IQR] for Dutch women was 0.9 [0.3–1.5]. The median Shannon
Diversity Indexes [IQR], and Kruskal Wallis p values for the other ethnic groups compared to
Dutch women, were: South Asian Surinamese women 0.8 [0.2–1.4] (p = 0.31), African Suri-
namese women 1.5 [0.5–1.9] (p< 0.01), Ghanaian women 0.9 [0.2–1.7] (p = 0.83), Turkish
women 1.0 [0.3–1.6] (p = 0.59), and Moroccan women 1.1 [0.4–1.7] (p = 0.16).
VMB correlates in multivariable logistic regression models
VMB correlates were determined for the three largest of the eight VMB groups as described in
the methods (Table 3). In adjusted analyses, being of African Surinamese and Ghanaian eth-
nicity, compared to Dutch ethnicity, was significantly associated with having a polybacterial G.
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vaginalis-containing VMB (adjusted odds ratio (aOR) 5.1, 95% confidence interval (CI) 2.1–
12.0 and aOR 4.8, 95% CI 1.8–12.6, respectively), and being of African Surinamese ethnicity
also with having a L. iners-dominated VMB (aOR 2.8, 95% CI 1.2–6.2). Other characteristics
independently associated with having a polybacterial G. vaginalis-containing VMB at p<0.05
were being in a steady relationship for less than 2 years (aOR 3.5, 95% CI 1.4–8.5), inconsistent
Fig 2. Prevalence of VMB groups by ethnic group. L = Lactobacillus; GV = Gardnerella vaginalis; VMB = vaginal microbiota. *Excluding
GV. A. Prevalence of six VMB groups by ethnic group. The error bars show the 95% confidence intervals for the prevalence of the three
Lactobacillus-dominated VMB groups combined and the three VMB groups not dominated by lactobacilli combined for each ethnic group.
B. The ‘Other VMB’ group was further subdivided into three subgroups: The prevalence of these subgroups is shown by ethnic group.
https://doi.org/10.1371/journal.pone.0181135.g002
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condom use with a casual sex partner in the past six months (aOR 3.2, 95% CI 1.0–9.9), and
currently not using hormonal contraception (aOR 0.5, 95% CI 0.3–0.8, for current use).
Discussion
More than a third (38.5%) of the women in our population-based study in Amsterdam had a
non-lactobacilli-dominated VMB, of which 83.6% resembled BV and 16.4% had a VMB domi-
nated by Bifidobacteriaceae (not including G. vaginalis), Corynebacterium, or pathobionts.
Women of sub-Saharan African descent (either African Surinamese or Ghanaian) were signifi-
cantly more likely to have a polybacterial G. vaginalis-containing VMB, and African Surinam-
ese women were significantly more likely to have a L. iners-dominated VMB, than Dutch
women after controlling for sociodemographic factors, sexual risk behaviors, vaginal cleansing
practices, and hormonal contraceptive use.
Table 3. VMB correlates: Multivariable logistic regression models comparing each VMB cluster to the L. crispatus-dominated cluster.
L. crispatus-dominated (n = 131) L. iners-dominated (n = 187) Polybacterial GV-containing
VMB (n = 134)
N (%)1 N (%)1 aOR (95% CI)2,3 N (%)1 aOR (95% CI)2,4
Ethnicity: Dutch 38 (29) 28 (15) ref 17 (13) ref
African Surinamese 17 (13) 36 (19) 2.8 (1.2–6.2)* 42 (31) 5.1 (2.1–12.0)*
S-Asian Surinamese 24 (18) 36 (19) 1.9 (0.9–4.0) 19 (14) 1.6 (0.7–4.0)
Turkish 17 (13) 33 (18) 2.1 (0.9–4.9) 12 (9) 1.1 (0.4–3.0)
Moroccan 20 (15) 32 (17) 2.1 (0.9–5.0) 19 (14) 2.4 (0.9–6.3)
Ghanaian 15 (11) 22 (12) 2.1 (0.8–5.4) 25 (19) 4.8 (1.8–12.6)*
Currently married 14 (11) 39 (21) 0.9 (0.3–2.4)
1 child births 23 (18) 60 (32) 1.5 (0.7–2.9)
Current hormonal contraception use 64 (49) 72 (39) 0.7 (0.4–1.1) 42 (31) 0.5 (0.3–0.8)*
Alcohol use in past 12 months 87 (66) 102 (55)
Steady relationship: None 81 (62) 86 (46) ref 63 (48) ref
<2 years 12 (9) 17 (9) 1.5 (0.6–3.7) 24 (18) 3.5 (1.4–8.5)*
2–5 years 23 (18) 35 (19) 1.3 (0.6–2.8) 28 (21) 2.2 (1.0–4.9)
6 years 14 (11) 47 (25) 2.5 (0.9–6.8) 17 (13) 1.9 (0.7–5.0)
Condom use in past six months:
No recent sex 51 (39) 50 (27) ref 38 (29) ref
Consistent5 (steady/casual partner) 27 (21) 28 (15) 1.1 (0.5–2.2) 22 (17) 0.9 (0.4–2.1)
Inconsistent6 (steady partner only) 46 (35) 95 (51) 1.7 (0.9–3.2) 58 (44) 1.4 (0.7–3.0)
Inconsistent6 (casual +/- steady partner) 7 (5) 13 (7) 2.5 (0.9–7.5) 15 (11) 3.2 (1.0–9.9)*
aOR = adjusted odds ratio; CI = confidence interval; GV = Gardnerella vaginalis; ref = reference category; S-Asian = South Asian; VMB = vaginal
microbiota.
Two separate multivariable logistic regression models were used to determine correlates of the L. iners-dominated VMB group and polybacterial G.
vaginalis-containing VMB group, respectively, each compared to the L. crispatus-dominated VMB group.
1 N (%) is shown for all variables in the reference column, but in the other two columns, only for variables associated with the outcome (the L. iners-
dominated VMB group or polybacterial G. vaginalis-containing VMB) at p<0.1 in unadjusted analyses (Fishers’ exact for categorical and Kruskal Wallis for
continuous data). The models were not adjusted for any other variables.
2 aORs with 95% CI that were statistically significant at p<0.1 are shown in bold, and those significant at p<0.05 are also indicated with *.
3,4 Participants dropped from the multivariable model due to missing values: n = 8 (3) and n = 5 (4), respectively.
5 Reported as mostly/always.
6 Reported as never/mostly not/sometimes.
https://doi.org/10.1371/journal.pone.0181135.t003
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While studies in multi-ethnic asymptomatic American populations have shown similar dif-
ferences between African-American women and women of other ethnicities before [1, 5, 17–
19], our study is the first to show this in a multi-ethnic population living in Europe. We note
some differences between our study and the American multi-ethnic studies: VMB dominated
by lactobacilli other than L. crispatus and L. iners (most notably L. gasseri and L. jensenii) were
less common, and the overall prevalence of a VMB resembling BV in White and Asian women
was higher, in our study. Hypotheses to explain the association between ethnicity and VMB
composition include differences in sociodemographic, behavioral, environmental, and genetic
factors. Our results suggest that genetic differences might play a role. First, our sampling strat-
egy balanced ethnicity and age, and we controlled our analyses for a large number of other
sociodemographic factors and behaviors. Second, our study included two groups of women of
sub-Saharan African descent: African Surinamese and Ghanaian women. The African Suri-
namese went from West-Africa to Suriname, a former Dutch colony in South America, in the
nineteenth century, and many migrated from Suriname to the Netherlands in the 1970s and
1980s due to an unstable political situation in Suriname. Ghanaians migrated to the Nether-
lands (and also to other European countries such as the UK and Germany) between 1974
and 1983, and again in the early 1990s, for economic and political reasons. Despite different
migration histories, both groups had higher adjusted odds of having a polybacterial G. vagina-
lis-containing VMB compared to Dutch women of a similar magnitude (aOR 5.1 and 4.8,
respectively). Macro-environmental factors are therefore unlikely to play a role, but the role of
cultural habits that women and their sexual partners take with them when they migrate, such
as diet and sexual, vaginal, and penile hygiene practices, cannot be ruled out (vaginal hygiene
practices were, however, not associated with VMB group in our study). A few studies have sug-
gested that genetic differences in vaginal mucosal immune responses might favor colonization
by L. iners over L. crispatus in women of African descent [36–38] but this has not yet been suf-
ficiently studied. We speculate that vaginal mucosal immune responses may have evolved dif-
ferently in sub-Saharan Africa compared to Europe or the Americas as a result of differences
in exposures at mucosal surfaces to types and quantities of pathogens and pathobionts.
The clustering we performed differentiated VMB groups not dominated by lactobacilli by
bacterial diversity, the relative abundances of the BV-associated taxa G. vaginalis, A. vaginae,
BVAB1, Mobiluncus species, and Prevotella species, and the relative abundance of Bifidobacter-
iaceae (not including G. vaginalis), Corynebacterium, and pathobionts. Others have also
reported on VMB groups differentiated by bacterial diversity and relative abundance of typical
BV-associated bacteria [1, 5, 17–19], but different research groups are not yet using consistent
VMB descriptions and categorizations making between-study comparisons difficult. VMBs
dominated by Bifidobacteriaceae (not including G. vaginalis), Corynebacterium, and patho-
bionts have been infrequently reported thus far [1, 19, 39]. A Russian study isolated four Bifi-
dobacterium species (B. bifidum, B. breve, B. adolescentis, and B. longum) in vaginal specimens
of healthy women of reproductive age, and these were capable of inhibiting pathobionts in
vitro [39]. While the clinical significance of the Corynebacterium VMB group is unclear, VMBs
dominated by pathobionts are likely associated with adverse reproductive health outcomes;
culture-based studies have consistently identified these pathobionts as causes of pregnancy
complications and neonatal sepsis [3, 40]. Of note, only 6% of women in our study had at least
1% relative abundance of a Streptococcus species in their VMB, whereas a recent systematic
review of culture-based studies concluded that the mean prevalence of rectovaginal carriage of
S. agalactiae was 17.9% worldwide and 19.0% in Europe [41]. These figures cannot be com-
pared directly due to differences in sampling (vaginal versus rectovaginal) and laboratory
methods (16S sequencing versus culture). However, further research is needed to explain these
differences and ensure that pathobionts are accurately identified in molecular studies. In
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addition, in our study, pathobionts occurred across VMB groups, including lactobacilli-domi-
nated VMB groups. A better understanding of when pathobionts become clinically relevant
(for example, at which relative or absolute abundance), and whether VMB groups or commu-
nity state types adequately capture those situations, is urgently needed.
The five VMB groups not dominated by lactobacilli in our study might require different
types of treatment or combinations of treatments. The three VMB groups resembling BV
might respond to metronidazole treatment, but the efficacy might differ depending on the rel-
ative abundances of key taxa such as G. vaginalis, A. vaginae and BVAB1 and/or the presence
of a biofilm (G. vaginalis is thought to initiate a vaginal biofilm by providing the scaffolding
needed for other anaerobes to colonize) [42]. In contrast, VMBs with high relative abundance
of pathobionts would require a different antibiotic treatment [40]. Clinicians should therefore
be enabled to differentiate between these conditions.
Our study was cross-sectional. The vaginal microbiota often fluctuate over time, and the
potential confounders that we included in our models (sexual risk behaviors, vaginal cleansing
practices, and hormonal contraceptive use) are also time-dependent. Furthermore, vaginal
microbiota are often influenced by the menstrual cycle [1, 18], and menstrual cycle data were
not collected in the HELIUS study. Transient vaginal dysbiosis may not be clinically relevant,
and data on the proportions of women who have persistent vaginal dysbiosis are needed. It
should also be noted that the data on the potential confounders were self-reported, and may
therefore suffer from social desirability bias.
The HELIUS study selected women at random from among those registered in Amsterdam
in the age range and ethnic groups of interest, and we selected our subsample from the
HELIUS sample. However, our subsample did suffer from participation bias and possibly
reporting bias. The Turkish and Moroccan participants, in particular, were much less likely
than the other groups to self-sample a vaginal swab and to complete a sexual behavior ques-
tionnaire [26]. They were also less likely to report sexual risk behaviors, which could be due to
actual differences in behaviors or in reporting of those behaviors. Our results related to the
Turkish and Moroccan groups should therefore be interpreted with caution. However, we
believe that these biases did not influence our main finding that women of sub-Saharan Afri-
can descent were much more likely to have a suboptimal VMB after controlling for potential
confounding factors than Dutch women. In the three ethnic groups included in those compar-
isons (Dutch, African Surinamese and Ghanaian), vaginal sampling rates were 94%, 87% and
71%, respectively. None of the characteristics that differed between those who self-sampled
and those who did not were associated with VMB composition in multivariable models, except
that Ghanaian women who self-sampled were more likely to be in a steady relationship of lon-
ger duration and to have had at least one child than Ghanaian women who declined self-sam-
pling [data not shown]. This suggests that Ghanaian women who participated may have a
lower risk of having a VMB not dominated by lactobacilli than those who did not, which only
strengthens our main finding.
We conclude that the overall prevalence of VMB not dominated by lactobacilli in women
aged 18–34 years in Amsterdam was high, and that women of sub-Saharan African descent
were more likely to have a polybacterial G. vaginalis-containing VMB than Dutch women
independent of modifiable behaviors. Further research is required to determine if these
women are also more likely to have persistent vaginal dysbiosis, and whether this contributes
to the higher prevalence of adverse reproductive outcomes in these groups. Our findings sup-
port hypotheses implicating the contribution of genetic causes to these differences, such as
those related to differences in vaginal mucosal immune response, and these should be further
investigated.
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